Body mass index and clinical outcomes in trastuzumab-treated metastatic breast cancer patients: An alternative explanation for the lack of association.

Body mass index and clinical outcomes in trastuzumab-treated metastatic breast cancer patients: An alternative explanation for the lack of association. Breast. 2018 Mar 09;: Authors: Nabi H, Diorio C PMID: 29530641 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29530641?dopt=Abstract

Source: Breast - March 9, 2018 Category: Cancer & Oncology Authors: Nabi H, Diorio C Tags: Breast Source Type: research

More News: Breast Cancer | Cancer | Cancer & Oncology | Herceptin